Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 4 1Phase 1 1

Status

Recruiting 4Completed 4Active not recruiting 4Withdrawn 1Suspended 1Not yet recruiting 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Head & Neck 7CNS 5Endocrine 4Dermatologic 4Tumor-Agnostic 2Thoracic 2Gastrointestinal 2Plasma cell 1Other solid neoplasm 1Other neoplasm 1Other hematologic neoplasm 1Other 1Myeloid 1Lymphoid 1

Conditions

Thyroid Carcinoma, Anaplastic 3Advanced Thyroid Cancer Patients Who Received Target Therapy 1

Interventions

lutetium Lu 177 dotatate 16Magnetic Resonance Spectroscopy 14gallium Ga 68 dotatate 9Specimen Handling 8Everolimus 8pembrolizumab 7cabozantinib 6Cisplatin 6fluorodopa F 18 5Etoposide 5trametinib 4surufatinib 4lanreotide 4dabrafenib 4cemiplimab 4X-Rays 4Temozolomide 4Nivolumab 4Lutetium-177 4Lutetium 4Fluorodeoxyglucose F18 4Carboplatin 4177Lu-octreotide, DOTA(0)-Tyr(3)- 4olaparib 3lenvatinib 3copper dotatate CU-64 3Transurethral Resection of Prostate 3Thyrotropin Alfa 3Surveys and Questionnaires 3Somatostatin 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Recruiting × dabrafenib × Endocrine × Clear all
NCT03975231 2026-04-08

Dabrafenib, Trametinib, and IMRT in Treating Patients With BRAF Mutated Anaplastic Thyroid Cancer

City of Hope Medical Center

Phase 1 Recruiting
6 enrolled
EndocrineHead & Neck

Thyroid Carcinoma, Anaplastic

NCT06195228 2025-08-14

A Retrospective and Prospective Real-world Study of Molecular Typing in the Treatment of Advanced Thyroid Cancer

Fudan University

Phase 4 Recruiting
800 enrolled
EndocrineHead & Neck

Advanced Thyroid Cancer Patients Who Received Target Therapy

NCT06362694 2024-04-12

Study of the Rechallenge Concept in Patients With BRAF-positive Anaplastic Thyroid Cancer After Progression on Anti-BRAF Therapy

Saint Petersburg State University, Russia

Phase 2 Recruiting
10 enrolled
EndocrineHead & Neck

Thyroid Carcinoma, Anaplastic

NCT06079333 2023-10-12

NEO-ATACT

Leiden University Medical Center

Phase 2 Recruiting
20 enrolled
EndocrineHead & Neck

Thyroid Carcinoma, Anaplastic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡